HR
ATEX icon

Howe & Rusling’s Anterix ATEX Stock Holding History

Howe & Rusling’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-125
Closed -$7K – 978
2021
Q2 		$7K Hold
125
– – ﹤0.01% 536
2021
Q1 		$6K Buy
+125
New +$5.14K ﹤0.01% 562

Other funds holding ATEX

OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCC
Bain Capital Credit Boston, Massachusetts $303M AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Howe & Rusling's ATEX Position: Q3 2021 in Review

Howe & Rusling sold out of Anterix (ATEX) in Q3 2021, closing a stake of 125 shares — an estimated $7K sold.

Howe & Rusling first reported a position in ATEX in Q1 2021 and held it in 2 quarters. The position peaked at $7K in Q2 2021. 106 funds tracked by Wall St. Rank hold ATEX as of Q3 2021.

  • Howe & Rusling reported no remaining Anterix position as of Q3 2021 after selling out during the quarter.
  • Howe & Rusling sold 125 Anterix shares in Q3 2021, an estimated $7K.
  • Howe & Rusling first reported a position in Anterix in Q1 2021 and held it in 2 quarters.
  • Howe & Rusling's Anterix position peaked at $7K in Q2 2021.
  • 106 funds tracked by Wall St. Rank held Anterix as of Q3 2021.

Based on Howe & Rusling's 13F filing for Q3 2021, filed 15 Nov 2021.